These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22913594)

  • 1. Developing microRNA therapeutics: approaching the unique complexities.
    Jackson AL; Levin AA
    Nucleic Acid Ther; 2012 Aug; 22(4):213-25. PubMed ID: 22913594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic potential of microRNA modulation.
    Jackson A; Linsley PS
    Discov Med; 2010 Apr; 9(47):311-8. PubMed ID: 20423675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bottleneck limitations for microRNA-based therapeutics from bench to the bedside.
    Chen Y; Zhao H; Tan Z; Zhang C; Fu X
    Pharmazie; 2015 Mar; 70(3):147-54. PubMed ID: 25980175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-coding RNAs: Therapeutic Strategies and Delivery Systems.
    Ling H
    Adv Exp Med Biol; 2016; 937():229-37. PubMed ID: 27573903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.
    Bernardo BC; Ooi JY; Lin RC; McMullen JR
    Future Med Chem; 2015; 7(13):1771-92. PubMed ID: 26399457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs.
    Nana-Sinkam SP; Croce CM
    IDrugs; 2010 Dec; 13(12):843-6. PubMed ID: 21154140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of small molecule modifiers of microRNAs for the treatment of HCV infection.
    Tripp VT; Young DD
    Methods Mol Biol; 2014; 1103():153-63. PubMed ID: 24318893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional significance of aberrantly expressed microRNAs in prostate cancer.
    Goto Y; Kurozumi A; Enokida H; Ichikawa T; Seki N
    Int J Urol; 2015 Mar; 22(3):242-52. PubMed ID: 25599923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs and other non-coding RNAs as targets for anticancer drug development.
    Ling H; Fabbri M; Calin GA
    Nat Rev Drug Discov; 2013 Nov; 12(11):847-65. PubMed ID: 24172333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-155: a Novel Armamentarium Against Inflammatory Diseases.
    Xiaoyan W; Pais EM; Lan L; Jingrui C; Lin M; Fordjour PA; Guanwei F
    Inflammation; 2017 Apr; 40(2):708-716. PubMed ID: 27981414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs: role and therapeutic targets in viral hepatitis.
    van der Ree MH; de Bruijne J; Kootstra NA; Jansen PL; Reesink HW
    Antivir Ther; 2014; 19(6):533-41. PubMed ID: 24642660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA therapeutics: Identification of novel targets leading to drug discovery.
    Qadir MI; Bukhat S; Rasul S; Manzoor H; Manzoor M
    J Cell Biochem; 2020 Feb; 121(2):898-929. PubMed ID: 31478252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting microRNAs for cell engineering and therapy.
    Bratkovič T; Glavan G; Strukelj B; Zivin M; Rogelj B
    Biotechnol Adv; 2012; 30(3):753-65. PubMed ID: 22286072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic advances in MicroRNA targeting.
    Montgomery RL; van Rooij E
    J Cardiovasc Pharmacol; 2011 Jan; 57(1):1-7. PubMed ID: 20729755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular mechanisms and therapeutic potential of microRNA-7 in cancer.
    Gu DN; Huang Q; Tian L
    Expert Opin Ther Targets; 2015 Mar; 19(3):415-26. PubMed ID: 25434362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs: biogenesis, function and applications.
    Chua JH; Armugam A; Jeyaseelan K
    Curr Opin Mol Ther; 2009 Apr; 11(2):189-99. PubMed ID: 19330724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNAs in cardiovascular diseases: current knowledge and the road ahead.
    Condorelli G; Latronico MV; Cavarretta E
    J Am Coll Cardiol; 2014 Jun; 63(21):2177-87. PubMed ID: 24583309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of microRNAs for therapeutics.
    Stenvang J; Lindow M; Kauppinen S
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1197-200. PubMed ID: 19021524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered microRNA therapeutics.
    Gibson NW
    J R Coll Physicians Edinb; 2014; 44(3):196-200. PubMed ID: 25318394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma.
    Young DD; Connelly CM; Grohmann C; Deiters A
    J Am Chem Soc; 2010 Jun; 132(23):7976-81. PubMed ID: 20527935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.